Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Journey Medical (DERM) Equity Average (2020 - 2025)

Journey Medical's Equity Average history spans 6 years, with the latest figure at $28.9 million for Q4 2025.

  • For the quarter ending Q4 2025, Equity Average rose 86.32% year-over-year to $28.9 million, compared with a TTM value of $28.9 million through Dec 2025, up 86.32%, and an annual FY2025 reading of $26.0 million, up 28.46% over the prior year.
  • Equity Average for Q4 2025 was $28.9 million at Journey Medical, up from $22.6 million in the prior quarter.
  • The five-year high for Equity Average was $41.7 million in Q1 2022, with the low at -$6.3 million in Q3 2021.
  • Average Equity Average over 5 years is $17.4 million, with a median of $16.1 million recorded in 2024.
  • Year-over-year, Equity Average surged 664.24% in 2022 and then crashed 90.17% in 2023.
  • Tracing DERM's Equity Average over 5 years: stood at $15.2 million in 2021, then surged by 42.3% to $21.6 million in 2022, then dropped by 12.61% to $18.9 million in 2023, then dropped by 17.84% to $15.5 million in 2024, then surged by 86.32% to $28.9 million in 2025.
  • Per Business Quant, the three most recent readings for DERM's Equity Average are $28.9 million (Q4 2025), $22.6 million (Q3 2025), and $20.4 million (Q2 2025).